Medical Device Network on MSN
AAIC26: Cognito sheds light on biological underpinnings of Alzheimer’s headset
Spectris increased CSF levels of multiple HDL-like lipid transport proteins, suggesting a “coordinated biological response” ...
Cognito Therapeutics Presents Exploratory Biomarker Data at AAIC 2026 Supporting Coordinated Modulation of Lipid Transport ...
Top-tier investor syndicate led by FoundersX Ventures, with participation from all existing investors and new investors Alzheimer’s Drug Discovery Foundation (ADDF), Starbloom Capital, IAG Capital and ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, today announced the publication of a study in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results